13D Filing: Viking Global and Arbutus Biopharma Corp (ABUS)
The calculation assumes that there are a total of 55,024,557 Common Shares outstanding as of April 30, 2017, as reported by the Issuer on its Quarterly Report on Form 10-Q for the period ended March 31...
